Talk:Olmesartan

Pharmacology High‑importance

	This article is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of Pharmacology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.PharmacologyWikipedia:WikiProject PharmacologyTemplate:WikiProject Pharmacologypharmacology articles
High	This article has been rated as High-importance on the project's importance scale.

Medicine Mid‑importance

	Medicine portal This article is within the scope of WikiProject Medicine, which recommends that medicine-related articles follow the Manual of Style for medicine-related articles and that biomedical information in any article use high-quality medical sources. Please visit the project page for details or ask questions at Wikipedia talk:WikiProject Medicine.MedicineWikipedia:WikiProject MedicineTemplate:WikiProject Medicinemedicine articles
Mid	This article has been rated as Mid-importance on the project's importance scale.

Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Olmesartan.

PubMed provides review articles from the past five years (limit to free review articles)
The TRIP database provides clinical publications about evidence-based medicine.
Other potential sources include: Centre for Reviews and Dissemination and CDC

Heading

can you eat grapefruit with this medicine? I don't think people should seek medical advice from talk pages ˥ Ǝ Ʉ H Ɔ I Ɯ (talk) 04:35, 9 July 2018 (UTC)[reply]

I do. I've been on it for two years. Just make sure you eat some foods high in potassium (oranges, orange juice, tomato juice, bananas) to keep your potassium levels up because Benicar makes you pee a lot —Preceding unsigned comment added by 12.164.212.250 (talk) 13:42, August 24, 2007 (UTC)

Olmesartan (an acid) and olmesartan medoxomil are different compounds and they should have their own pages. Olmesartan medoxomil is ester prodrug of olmesartan that is an acid.--Tanevala (talk) 10:22, 2 April 2014 (UTC)[reply]

CELIAC Disease Warning

Reports involving Benicar diarrhea problems suggest that the symptoms may not appear until months or even years after an individual first uses the drug. Therefore, if longer studies had been conducted the drug maker could have discovered the connection and provided warnings for consumers and the medical community much earlier - See more at: http://www.youhavealawyer.com/blog/2014/03/28/benicar-diarrhea-problems/#sthash.IxGPpe2m.dpuf — Preceding unsigned comment added by Notadr (talk • contribs) 20:08, 7 April 2014 (UTC)[reply]

Confusion between the drug and the pro-drug

I don't have access to reference 1 to check, but I think that the Chembox is showing the data for the prodrug Olmesartan medoxomil, and the lede also begins with the name of the prodrug (vs the title which is for the drug). While the information is all useful there needs to be clarity about what the principle subject of the article is and better clarity about when the prodrug is being discussed vs the drug. --The chemistds (talk) 09:41, 12 May 2014 (UTC)[reply]

ARB? the article uses A R 'antagonists', but uses ARB abbreviation.

I wanted to resolve the problem of 'ARB' being used without being defined. I usually do that by spelling out e.g. 'Angiotensin II Receptor Blockers (ARBs)', hence I would change 'antagonists' to 'blockers'.

But it is used in two places, in one reference. There is History/see-also 'Discovery and development of angiotensin receptor 'blockers ' The link 'angiotensin II receptor antagonist' in the article goes to the page 'Angiotensin II receptor blocker' (many references in that page use ARBs)

But the Category uses 'antagonists' I don't think I should be changing this everywhere.

Is there a common understanding that the term is ARB?

I could just also say 'angiotensin II receptor antagonist - frequently referred to as angiotensin receptor blockers (ARBs)' but that is clunky.

?? ˥ Ǝ Ʉ H Ɔ I Ɯ (talk) 03:16, 26 September 2024 (UTC)[reply]

@Mimarx Usually for this I find the first time the term is used and spell it out in full then put the abbreviation beside it. so for example "blah blah blah angiotensin II receptor antagonist (ARBs)" and then use the abbreviation throughout the article. With uncommon abbreviations I would also argue it's hepful to do this in every section that it's used. MOS:1STOCC might be a helpful read. IntentionallyDense (talk) 13:57, 26 September 2024 (UTC)[reply]